Characterisation of Hepatitis C Virus antiviral resistance in the era of direct acting antivirals
Hepatitis C Virus infects an estimated 71 million people world wide and accounts for approxi- mately 399,000 deaths per year from end stage liver failure due to cirrhosis or hepatocellular carcinoma. The development of direct acting antivirals (DAAs) has led to the elimination of the HCV infection,...
Үндсэн зохиолч: | Smith, D |
---|---|
Бусад зохиолчид: | Barnes, E |
Формат: | Дипломын ажил |
Хэл сонгох: | English |
Хэвлэсэн: |
2019
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
-н: Hang Zhang, зэрэг
Хэвлэсэн: (2023-11-01) -
Hepatitis C virus pharmacogenomics in Latin American populations: implications in the era of direct-acting antivirals
-н: Trinks J, зэрэг
Хэвлэсэн: (2017-03-01) -
Mechanisms of Hepatitis C Viral Resistance to Direct Acting Antivirals
-н: Asma Ahmed, зэрэг
Хэвлэсэн: (2015-12-01) -
Molecular Epidemiology and Baseline Resistance of Hepatitis C Virus to Direct Acting Antivirals in Croatia
-н: Petra Simicic, зэрэг
Хэвлэсэн: (2022-07-01) -
Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy
-н: Chung-Feng Huang, зэрэг
Хэвлэсэн: (2020-07-01)